PCR Technologies Market: Growth, Size, Share, and Trends

Report Code AST 7880
Published in Oct, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

PCR Technologies Market by Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostic Applications), Technique (Reverse Transcription PCR, qPCR), End-user (Hospital Labs, Diagnostic Labs) - Global Forecasts to 2030

Overview

The global PCR technologies market growth forecasted to transform from USD 14.61 Billion in 2024 to USD 21.89 Billion by 2030, driven by a CAGR of 7.0%.

Many factors that drive market growth are interlinked. For instance, advancements in technology support growth. Simultaneously, application in diagnostic labs increases their use in various healthcare settings. There is also a more significant trend in personalized medicine, driving the demand for this market. Higher applications in life sciences, such as disease detection, genomics, and cell analysis, further expand its application. Increased investment by the public and private sector and higher awareness increases the application of this device.

The escalating prevalence of infectious diseases has prompted organisations such as the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) of the US to facilitate the approval processes of PCR testing devices along with other associated technologies. Notably in the era of COVID-19, such speedy approvals have been beneficial in addressing efficiently the management of public health crises and in the quick deployment of diagnostic solutions. Considering these aspects, Government agencies tend to be influential in an economy and as such, the market for PCR technology is relatively more active encouraging the market’s resilience to emerging health challenges.

Attractive Opportunities in the PCR Technologies Market

North America

The increasing incidence of infectious diseases and constant improvements in creating innovative PCR technologies play a vital role in the North American market growth.

The development of novel and innovative products and company initiatives, such as partnerships, product launches, approvals and acquisitions, have supported market growth.

The rise in the development of advanced technologies such as digital PCR, multiplex PCR, and high-throughput PCR systems is an emerging opportunity for the prominent market players.

North America held the largest share of 44.5% of the PCR technologies market in 2023.

Market growth will be supported by increasing funding, the automation in PCR, and an increasing demand for molecular diagnostics.

Global PCR Technologies Market Dynamics

Driving Forces: Technological Advancement

Advances in technology have dramatically improved the sensitivity, specificity, and efficiency of PCR techniques. Newer techniques, such as real-time PCR and digital PCR, have undergone a drastic transformation that makes them more sensitive and precise. Indeed, applications of PCR have dramatically increased within the past few years. It has become a tool for genetic research and personalized medicine. Furthermore, PCR has become more accessible by coupling it with microfluidics and further advanced automation, making it more efficient in the laboratory. New reagents improve the quality and consistency of the results of PCR. Further research in such technologies will offer new opportunities in research and diagnostics.

Also, there has been several progressions due to the miniaturization of point-of-care testing (PoCT)-PCR technology, which includes shortening assay times, reducing reagent volumes, and performing rapid thermal cycling. Notably, the impact of these miniaturized systems has been felt during public health emergencies such as the COVID-19 pandemic, as they facilitated the rapid diagnosis and management of outbreaks. rephrase it in business professional language. Repeated cycle techniques like PCR.Ai have been incorporated in a PCR workflow to make laboratory testing simple and less time consuming by automating the processes of interpreting and validating results. All these technologies advancements helps in growing demand for PCR products in the market.

Restraining Factors: High Costs of Equipment

High investments required to maintain such systems have been one of the factors restraining the market's growth, mainly amongst small laboratories and healthcare facilities in developing countries, which cannot readily compete with such prices. The high capital requirement for highly advanced PCR instruments discourages many low-capital institutions from implementing PCR technology routinely for diagnosis and research. Such direct financial costs can disadvantage critical applications like infectious disease detection and genetic evaluations. Maintenance costs, consumables, personnel training, and technical support also enhance the long-term sustainability of PCR technology. Laboratories can incur heavy costs associated with acquisition of PCR instruments such as standard PCR, qPCR, RT-PCR machines. The price range is wide owing to the kind, features and operational capabilities of the apparatus in question. The cost is escalating due to factors such as automation, the volume of throughput, how much activities can be multiplexed and their sensitivity. During long and extensive testing operations such as those conducted during the outbreak of the COVID-19 diseases, a need for more than one equipment necessitated substantial construction costs, thereby emphasizing the impact of new developments in technology on healthcare facilities and research organizations.

 

Opportunities: Emerging Application of PCR Technology

PCR is highly applied in liquid biopsies to analyze circulating tumor DNA (ctDNA) in blood samples. It is a non-invasive method with which it is possible to detect cancer early, monitor progression, and assess the efficiency of treatments after identifying specific genetic changes of ctDNA. PCT Technology is also incorporated into point-of-care diagnostic equipment to diagnose infectious diseases rapidly, such as COVID-19, HIV, and influenza. Such advancements as isothermal PCR and microfluidic PCR systems enable susceptible and precise tests even outside the confines of a lab. This way, it delivers speedy results for health professionals to hasten treatment decisions, especially in regions with less advanced medical infrastructure.

Genomic medicine is increasingly incorporating digital polymerase chain reaction (dPCR) technology into its usage especially for minimal residual disease monitoring, rare mutation screening, and gene expression assaying. Its high sensitivity and quantitative power greatly suit these applications. Recent developments in techniques like photonic PCR and extreme PCR, which enhance amplification and detection rates, justify the use of these techniques even in point of care, rapid testing environments.

Challenges: Inhibition and Sensitivity

The significant inhibitory challenges in PCR technologies are inhibition and sensitivity, making these technologies less precise and ineffective in all applications. PCR processes are prone to inhibitors in biological samples like blood, soil, or food. Such an inhibitor can interfere with the DNA polymerase enzyme's ability to amplify DNA. Some examples of these inhibitors include substances like hemoglobin, bile salts, and chemicals from DNA extraction procedures. When it is present, it can block or even totally prevent the amplification of the DNA, which leads to false negatives or partial results.

Despite being extremely sensitive, there are certain limitations. PCR does not amplify DNA efficiently at low concentrations of the target, like infections in the early stages of a disease or those genetic mutations that occur in less than one percent of a population. External DNA contamination is also shown as false positives. The challenge here is maintaining the sensitivity of the technique whereby the minimal amounts of DNA can be sensed without allowing contamination or non-specific amplification, which remains a significant issue in PCR technologies.

Global PCR Technologies Market Ecosystem Analysis

The PCR technologies market ecosystem includes various product, technique, applications. PCR technologies manufacturers are manufacturing, qPCR instruments, RT-PCR instruments, thermal cyclers, reagents, consumables, softwares and other systems. These products are essential applications such as environment, genetic sequencing, genotyoping, diagnostics etc. Other than this the end users includes laboratories (hospital based and diagnostic), research organisations, pharmaceutical & biotechnological companies.

 

Reagents and consumables to register most significant market share during study period

In PCR, the reagents are the chemicals necessary to amplify DNA, including the primer, nucleotides, DNA polymerase, buffers, etc. The consumables are single-use items such as PCR tubes, plates, pipette tips, and sealing films, used in every PCR procedure but discarded afterward. Reagents and consumables constitute the largest market share for PCR technologies since they are essential for every PCR, unlike PCR instruments. It includes new reagents, such as primers, nucleotides, enzymes, and consumables in tubes and plates. There is a steady demand for high-throughput laboratories for diagnostics and research in which multiple PCR tests can run. Moreover, the vast range of applications in clinical diagnostics, genetic research, and forensic analysis often need specialized reagents, which drives up the market share in this segment.The advent of disease diagnosis through PCR, more particularly after the onset of COVID-19, has significantly increased the consumption of reagents such as enzymes, primers, probes, among other consumables. However, the development of new formulative reagents has brought in additional usage as they have enhanced the sensitivity and specificity and enabled multiplexing. Given all these factors, the demand growth of the reagent market is likely to persist for as long as there are clinical diagnostics and research undertakings in the broader phenomenon of PCT technology, which incorporates PCR technology.

Diagnostic laboratories to hold largest share in end-user market from 2024 to 2030

Diagnostic laboratories are leaders in the PCR market since they play a critical role in diagnosing and prognostic diseases. PCR is commonly used for diagnosing infectious diseases such as novel COVID-19, HIV, and hepatitis; genetic diseases; and cancer because of the accuracy and quick generation of results. The continued use of PCR technologies in the market for screening and real-time testing boosts the need for molecular diagnostics, driving growth in this market. Aside from that, the appearance of personalized medicine and high awareness of the early detection of diseases has heightened their dependency on PCR in such laboratories. Moreover, the persistent requirement for routine tests, especially during pandemics and epidemics, further enhances their market presence. The demand for PCR technology is on rise since the diagnostic labs have to carry out extensive testing in different disease areas such as infectious diseases, cancer or genetic disorders. Furthermore, the importance of diagnostic laboratories as the main consumers of PCR technology has also been strengthened owing to the increasing attention being given to molecular diagnostics in the context of precision medicine as well as in the search for new pathogens.

Asia Pacific register highest CAGR in PCR technologies market during forecast period

The Asia-Pacific region has the highest CAGR in the PCR market because of several factors. The rising infectious diseases and chronic conditions will increase demand for advanced diagnostic tools such as PCR. In addition, higher investments in healthcare infrastructure, particularly in China and India, have fuelled the adoption of PCR technologies. The expansion of research and development activities, government initiatives to increase the accessibility of healthcare, and the expansion of the pharmaceutical and biotechnology industry are further boosting these higher growth rates. A large population in the region, with more significant medical tourism, is expanding the market further and has rapidly enhanced the demand for PCR technologies.

Asia Pacific has become one of the leading regions for carrying out clinical trials and diagnostic testing, owing to lower costs and the availability of skilled personnel, which is causing demand for PCR technology to increase. The increasing emphasis on precision medicine, as well as the rapid growth of the biotechnology sector in the region, has resulted in a higher adoption of PCR technologies. The wave of investment in PCR technology for mass testing and research activities fueled by the Covid 19 pandemic has led to significant growth in the market in the region.

HIGHEST CAGR MARKET IN 2023
CHINA FASTEST GROWING MARKET IN THE REGION

Recent Developments of PCR Technologies Market

  • Agreements: In 2023, Bio-Rad Laboratories, Inc. and QIAGEN entered into an agreement to settle their patent dispute pending in the US District Court of Delaware according to a global settlement and patent cross-licensing agreement relating to digital PCR technology.
  • Partnership: In 2023, Thermo Fisher Scientific (US) partnered with Pfizer (US) to gain access to NGS-associated testing for cancer.
  • Acquisition: In 2024, F. Hoffman-La Roche Ltd. (Switzerland) acquired TIB Molbiol (Germany) to include infectious diseases in its PCR products portfolio.
  • Agreement: In 2022, Bio-Rad Laboratories Inc. (US) entered into an agreement with NuProbe (US) to expand its business to multiplexed digital PCR assays.

Key Market Players

Want to explore hidden markets that can drive new revenue in PCR Technologies Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2030
Base Year Considered 2023
Forecast period 2024-2030
Forecast units Value (USD Million/USD Billion)
Segments covered Product, Technique, Application, End User, and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Key Questions Addressed by the Report

What will the market share of the global technologies market be within five years?
The PCR technologies market is projected to reach USD 21.89 Billion by 2030 from USD 14.61 in 2024, growing at a CAGR of 7.0% during the forecast period.
Which product type segment has the largest share in the PCR technologies market?
Reagents and consumables are expected to exhibit the largest share.
What major strategies are leading players adopting to enter emerging regions?
Agreements, partnerships, collaboration, expansion, product launches, and product approvals represent the major growth strategies adopted by major market players.
What are the major factors likely to hamper the growth of the PCR technologies market?
Premium costs, technical limitations of PCR equipment, and stringent regulatory guidelines associated with medical devices can restrict the growth of the PCR technologies market.
Which end-user segment will likely show the highest growth in the PCR technologies market?
Diagnostic Laboratories are expected to grow at the highest rate in the end-user market.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the PCR Technologies Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
27
RESEARCH METHODOLOGY
31
EXECUTIVE SUMMARY
46
PREMIUM INSIGHTS
51
MARKET OVERVIEW
55
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing outbreaks of infectious diseases/viral persistence
    - Development of miniaturized and portable point-of-care testing devices
    - Integration of PCR technology with automation and data analysis tools
    - High demand for technologically advanced molecular diagnostics
    RESTRAINTS
    - Premium product pricing
    - Dearth of skilled healthcare professionals
    OPPORTUNITIES
    - Increased investments in laboratory infrastructure
    - Rising number of applications in rare sequence detection
    CHALLENGES
    - Technical limitations
    - Increased pricing pressure on market players
  • 5.3 VALUE CHAIN ANALYSIS
    RESEARCH & DEVELOPMENT
    RAW MATERIAL PROCUREMENT AND MANUFACTURING
    DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
  • 5.4 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.5 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.6 PATENT ANALYSIS
    LIST OF MAJOR PATENTS
  • 5.7 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.8 TRADE DATA ANALYSIS
    IMPORT DATA FOR HS CODE 3822
    EXPORT DATA FOR HS CODE 3822
  • 5.9 PRICING ANALYSIS
    PRICE TRENDS OF PCR TECHNOLOGIES, BY REGION
    INDICATIVE SELLING PRICE OF PCR TECHNOLOGY PRODUCTS, BY REGION, 2021–2023
    AVERAGE SELLING PRICE TREND, BY REGION
    - Average selling price trend of PCR technology equipment, by region
    - Average selling price trend of PCR instruments, by key player
  • 5.10 UNMET NEEDS AND KEY PAIN POINTS
  • 5.11 ECOSYSTEM ANALYSIS
  • 5.12 SUPPLY CHAIN ANALYSIS
    MANUFACTURING COMPANIES
    SALES & DISTRIBUTION AGENTS
    END USERS
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.14 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Thermal cyclers
    - Real-time quantitative PCR
    - Portable and point-of-care PCR
    COMPLEMENTARY TECHNOLOGIES
    - Next-generation sequencing
    - Microarrays
    - Lab-on-a-chip devices
    - Robotics and automation
    ADJACENT TECHNOLOGIES
    - Mass spectrometry
    - Single-cell sequencing
    - Fluorescence in situ hybridization
  • 5.15 REGULATORY LANDSCAPE
    REGULATORY ANALYSIS
    - North America
    - Europe
    - Asia Pacific
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.16 INVESTMENT AND FUNDING SCENARIO
  • 5.17 REIMBURSEMENT SCENARIO ANALYSIS
  • 5.18 IMPACT OF AI/GEN AI ON PCR TECHNOLOGIES MARKET
PCR TECHNOLOGIES MARKET, BY PRODUCT
94
  • 6.1 INTRODUCTION
  • 6.2 REAGENTS AND CONSUMABLES
    INCREASING USE OF DPCR-BASED ANALYTICAL PROCEDURES IN GENETIC RESEARCH AND FORENSICS TO DRIVE MARKET
  • 6.3 INSTRUMENTS
    RISING AVAILABILITY OF TECHNOLOGICALLY ADVANCED AND INNOVATIVE PCR INSTRUMENTS TO FUEL MARKET GROWTH
  • 6.4 SOFTWARE AND SERVICES
    GROWING DEMAND FOR SPECIALIZED PCR ANALYSIS SOFTWARE FOR ONCOLOGY STUDIES AND FORENSICS TO SPUR MARKET GROWTH
PCR TECHNOLOGIES MARKET, BY TECHNIQUE
99
  • 7.1 INTRODUCTION
  • 7.2 REAL-TIME PCR
    RISING ADOPTION OF REAL-TIME PCR AMONG RESEARCHERS AND HEALTHCARE PROFESSIONALS TO PROPEL MARKET GROWTH
  • 7.3 CONVENTIONAL PCR
    COST-EFFECTIVENESS AND EASE OF USAGE IN ROUTINE CLONING, GENOTYPING, AND MUTATION ANALYSIS TO FUEL MARKET GROWTH
  • 7.4 DIGITAL PCR
    FASTER RESULTS WITH LOWER MARGIN ERRORS TO DRIVE ADOPTION
  • 7.5 REVERSE TRANSCRIPTION PCR
    HIGHER SENSITIVITY FOR MEASURING CHANGES IN GENE EXPRESSION TO AUGMENT MARKET GROWTH
  • 7.6 HOT-START PCR
    BETTER REACTION SPECIFICITY WITH LOWER ERROR RATES TO FAVOR MARKET GROWTH
  • 7.7 MULTIPLEX PCR
    COST-EFFECTIVENESS AND HIGH THROUGHPUT TO AID MARKET GROWTH
  • 7.8 OTHER PCR TECHNIQUES
PCR TECHNOLOGIES MARKET, BY APPLICATION
120
  • 8.1 INTRODUCTION
  • 8.2 DIAGNOSTIC APPLICATIONS
    UNAVAILABILITY OF REIMBURSEMENTS FOR CLINICAL DIAGNOSTIC TESTS TO LIMIT MARKET GROWTH
  • 8.3 GENOTYPING
    LARGE TARGET PATIENT POPULATION FOR CANCER DIAGNOSIS TO AUGMENT MARKET GROWTH
  • 8.4 NUCLEIC ACID DETECTION
    RISING PREVALENCE OF INFECTIOUS DISEASES TO BOOST MARKET GROWTH
  • 8.5 GENE EXPRESSION ANALYSIS
    INCREASED R&D FUNDING AND GRANTS FOR PCR TO FAVOR MARKET GROWTH
  • 8.6 NUCLEIC ACID SYNTHESIS
    INCREASED FOCUS ON PERSONALIZED AND PRECISE MEDICINES TO SUPPORT MARKET GROWTH
  • 8.7 GENETIC SEQUENCING
    TECHNOLOGICAL IMPROVEMENTS AND REDUCED COSTS OF SEQUENCING TO FUEL MARKET GROWTH
  • 8.8 ENVIRONMENTAL APPLICATIONS
    STRICT GOVERNMENT ENVIRONMENTAL POLICIES TO PROMOTE USE OF PCR
  • 8.9 STANDARD VALIDATION/VERIFICATION
    NEED FOR REGIONAL/GLOBAL VALIDATION FOR COMMERCIAL/NON-COMMERCIAL GUIDELINE FRAMING TO DRIVE MARKET
  • 8.10 OTHER APPLICATIONS
PCR TECHNOLOGIES MARKET, BY END USER
131
  • 9.1 INTRODUCTION
  • 9.2 HOSPITAL LABORATORIES
    RISING PUBLIC AWARENESS OF ROUTINE CHECKUPS TO SUPPORT MARKET GROWTH
  • 9.3 DIAGNOSTIC LABORATORIES
    ESTABLISHMENT OF INDEPENDENT SPECIALIZED DIAGNOSTIC LABORATORIES TO PROPEL MARKET GROWTH
  • 9.4 ACADEMIC AND GOVERNMENT ORGANIZATIONS
    INCREASED GOVERNMENT SUPPORT FOR GENOME-BASED RESEARCH TO DRIVE MARKET
  • 9.5 PHARMA-BIOTECH COMPANIES
    INCREASING R&D INITIATIVES BY PHARMA-BIOTECH COMPANIES TO DRIVE ADOPTION OF PCR TECHNOLOGIES
  • 9.6 OTHER END USERS
PCR TECHNOLOGIES MARKET, BY REGION
138
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - US to dominate North American PCR technologies market during study period
    CANADA
    - Supportive government initiatives for genomics research to aid market growth
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Presence of well-established pharmaceutical and R&D industry to augment market growth
    FRANCE
    - Increasing investments in life science R&D for infrastructural development to favor market growth
    UK
    - Rising acceptance of genome-based diagnosis by clinicians and healthcare professionals to spur market growth
    ITALY
    - Supportive government policies and high healthcare expenditure to boost market growth
    SPAIN
    - Increasing funding for life science research and pharmaceutical drug development to boost market growth
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Improved public access to modern healthcare facilities and advanced genomics research to fuel market growth
    JAPAN
    - Well-established healthcare infrastructure and advanced cancer research activities to support market growth
    INDIA
    - Presence of large target patient population and high government healthcare expenditure to support market growth
    AUSTRALIA
    - High healthcare expenditure to drive adoption of advanced PCR technologies
    SOUTH KOREA
    - Improved medical tourism and prevalence of chronic diseases to propel market growth
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Growing focus on proteomics and genomics research to drive market
    MEXICO
    - Favorable trade agreements to support imports and improve accessibility to PCR instruments
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Advancements in healthcare infrastructure and increased focus on personalized medicines to fuel market growth
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
195
  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PCR TECHNOLOGIES MARKET
  • 11.3 REVENUE ANALYSIS, 2019–2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
    GLOBAL PCR INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2023
    GLOBAL PCR REAGENTS AND CONSUMABLES MARKET SHARE, BY KEY PLAYER, 2023
    GLOBAL PCR SOFTWARE AND SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Product footprint
    - Application footprint
    - Technique footprint
    - End-user footprint
    - Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPANY BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.8 PRODUCT/BRAND COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES AND APPROVALS
    DEALS
COMPANY PROFILES
215
  • 12.1 KEY PLAYERS
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    F. HOFFMANN-LA ROCHE LTD.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    QIAGEN
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    - MnM view
    DANAHER CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    ABBOTT
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    TAKARA BIO INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    ANALYTIK JENA GMBH+CO. KG
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    MERCK KGAA
    - Business overview
    - Products/Services/Solutions offered
    BIONEER CORPORATION
    - Business overview
    - Products/Services/Solutions offered
    PERKINELMER
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    BECTON, DICKINSON AND COMPANY
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    STANDARD BIOTOOLS
    - Business overview
    - Products/Services/Solutions offered
    HOLOGIC, INC.
    - Business overview
    - Products/Services/Solutions offered
    - Recent developments
    LONZA
    - Business overview
    - Products/Services/Solutions offered
    ILLUMINA, INC.
    - Business overview
    - Products/Services/Solutions offered
    SANSURE BIOTECH INC.
    - Business overview
    - Products/Services/Solutions offered
  • 12.2 OTHER PLAYERS
    PROMEGA CORPORATION
    LIMING BIO
    EPPENDORF SE
    TRANSGEN BIOTECH CO., LTD.
    DAAN GENE CO., LTD.
    BIOBASE GROUP
    NIPPON GENETICS EUROPE
    BIOMÉRIEUX
    DAIICHI SANKYO COMPANY, LIMITED
    STILLA
    GENSCRIPT
APPENDIX
296
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 PCR TECHNOLOGIES MARKET: STUDY ASSUMPTIONS
  • TABLE 2 PCR TECHNOLOGIES MARKET: RISK ASSESSMENT
  • TABLE 3 NUMBER OF REPORTED CASES OF INFECTIOUS DISEASES, JANUARY 2019–DECEMBER 2022
  • TABLE 4 ADVANTAGES AND DISADVANTAGES OF REAL-TIME POINT-OF-CARE RT-PCR DEVICES
  • TABLE 5 PCR TECHNOLOGIES MARKET: PORTER’S FIVE FORCES
  • TABLE 6 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%)
  • TABLE 7 PCR TECHNOLOGIES MARKET: LIST OF MAJOR PATENTS, JANUARY 2022–DECEMBER 2024
  • TABLE 8 PCR TECHNOLOGIES MARKET: LIST OF KEY CONFERENCES AND EVENTS, JANUARY 2024–DECEMBER 2025
  • TABLE 9 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 10 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2019−2023 (USD THOUSAND)
  • TABLE 11 INDICATIVE SELLING PRICE OF PCR TECHNOLOGY PRODUCTS, BY REGION, 2021–2023 (USD)
  • TABLE 12 AVERAGE SELLING PRICE OF PCR INSTRUMENTS, BY KEY PLAYER, 2023 (USD)
  • TABLE 13 PCR TECHNOLOGIES MARKET: CURRENT UNMET NEEDS
  • TABLE 14 PCR TECHNOLOGIES MARKET: ROLE IN ECOSYSTEM
  • TABLE 15 US: CLASSIFICATION OF PCR TECHNOLOGY-ASSOCIATED DIAGNOSTIC DEVICES
  • TABLE 16 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 17 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 18 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 19 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 25 REIMBURSEMENT CODES FOR PCR TESTING, 2023
  • TABLE 26 PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 27 PCR TECHNOLOGIES MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 28 PCR TECHNOLOGIES MARKET FOR INSTRUMENTS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 29 PCR TECHNOLOGIES MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 30 PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 31 REAL-TIME PCR MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 32 REAL-TIME PCR MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 33 REAL-TIME PCR MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 34 REAL-TIME PCR MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 35 CONVENTIONAL PCR MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 36 CONVENTIONAL PCR MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 37 CONVENTIONAL PCR MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 38 CONVENTIONAL PCR MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 39 DIGITAL PCR MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 40 DIGITAL PCR MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 41 DIGITAL PCR MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 42 DIGITAL PCR MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 43 ONE-STEP RT-PCR VS. TWO-STEP RT-PCR
  • TABLE 44 REVERSE TRANSCRIPTION PCR MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 45 REVERSE TRANSCRIPTION PCR MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 46 REVERSE TRANSCRIPTION PCR MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 47 REVERSE TRANSCRIPTION PCR MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 48 BENEFITS AND CONSIDERATIONS OF HOT-START PCR TECHNOLOGY
  • TABLE 49 HOT-START PCR MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 50 HOT-START PCR MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 51 HOT-START PCR MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 52 HOT-START PCR MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 53 MULTIPLEX PCR MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 54 MULTIPLEX PCR MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 55 MULTIPLEX PCR MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 56 MULTIPLEX PCR MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 57 OTHER PCR TECHNIQUES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 58 OTHER PCR TECHNIQUES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 59 OTHER PCR TECHNIQUES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 60 OTHER PCR TECHNIQUES MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 61 PCR TECHNOLOGIES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 62 PCR TECHNOLOGIES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 63 PCR TECHNOLOGIES MARKET FOR GENOTYPING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 64 PCR TECHNOLOGIES MARKET FOR NUCLEIC ACID DETECTION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 65 PCR TECHNOLOGIES MARKET FOR GENE EXPRESSION ANALYSIS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 66 PCR TECHNOLOGIES MARKET FOR NUCLEIC ACID SYNTHESIS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 67 PCR TECHNOLOGIES MARKET FOR GENETIC SEQUENCING, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 68 PCR TECHNOLOGIES MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 69 PCR TECHNOLOGIES MARKET FOR STANDARD VALIDATION/VERIFICATION, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 70 PCR TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 71 PCR TECHNOLOGIES MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 72 PCR TECHNOLOGIES MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 73 PCR TECHNOLOGIES MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 74 PCR TECHNOLOGIES MARKET FOR ACADEMIC AND GOVERNMENT ORGANIZATIONS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 75 PCR TECHNOLOGIES MARKET FOR PHARMA-BIOTECH COMPANIES, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 76 PCR TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 77 PCR TECHNOLOGIES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: KEY MACROINDICATORS
  • TABLE 79 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 80 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 81 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 82 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 83 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 84 US: KEY MACROINDICATORS
  • TABLE 85 US: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 86 US: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 87 CANADA: KEY MACROINDICATORS
  • TABLE 88 CANADA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 89 CANADA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 90 EUROPE: KEY MACROINDICATORS
  • TABLE 91 EUROPE: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 92 EUROPE: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 93 EUROPE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 94 EUROPE: PCR TECHNOLOGIES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 95 EUROPE: PCR TECHNOLOGIES MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 96 GERMANY: KEY MACROINDICATORS
  • TABLE 97 GERMANY: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 98 GERMANY: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 99 FRANCE: KEY MACROINDICATORS
  • TABLE 100 FRANCE: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 101 FRANCE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 102 UK: KEY MACROINDICATORS
  • TABLE 103 UK: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 104 UK: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 105 ITALY: KEY MACROINDICATORS
  • TABLE 106 ITALY: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 107 ITALY: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 108 SPAIN: KEY MACROINDICATORS
  • TABLE 109 SPAIN: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 110 SPAIN: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 111 REST OF EUROPE: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 112 REST OF EUROPE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 114 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 119 CHINA: KEY MACROINDICATORS
  • TABLE 120 CHINA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 121 CHINA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 122 JAPAN: KEY MACROINDICATORS
  • TABLE 123 JAPAN: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 124 JAPAN: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 125 INDIA: KEY MACROINDICATORS
  • TABLE 126 INDIA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 127 INDIA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 128 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 129 AUSTRALIA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 130 AUSTRALIA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 131 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 132 SOUTH KOREA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 133 SOUTH KOREA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 134 REST OF ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 135 REST OF ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 136 LATIN AMERICA: KEY MACROINDICATORS
  • TABLE 137 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 138 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 139 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 140 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 141 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 142 BRAZIL: KEY MACROINDICATORS
  • TABLE 143 BRAZIL: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 144 BRAZIL: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 145 MEXICO: KEY MACROINDICATORS
  • TABLE 146 MEXICO: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 147 MEXICO: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 148 REST OF LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 149 REST OF LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 150 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 151 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
  • TABLE 152 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 153 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 154 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY APPLICATION, 2022–2030 (USD MILLION)
  • TABLE 155 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 156 GCC COUNTRIES: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 157 GCC COUNTRIES: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 158 REST OF MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
  • TABLE 159 REST OF MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
  • TABLE 160 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PCR TECHNOLOGIES MARKET
  • TABLE 161 PCR TECHNOLOGIES MARKET: DEGREE OF COMPETITION
  • TABLE 162 PCR TECHNOLOGIES MARKET: PRODUCT FOOTPRINT
  • TABLE 163 PCR TECHNOLOGIES MARKET: APPLICATION FOOTPRINT
  • TABLE 164 PCR TECHNOLOGIES MARKET: TECHNIQUE FOOTPRINT
  • TABLE 165 PCR TECHNOLOGIES MARKET: END-USER FOOTPRINT
  • TABLE 166 PCR TECHNOLOGIES MARKET: REGION FOOTPRINT
  • TABLE 167 PCR TECHNOLOGIES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 168 PCR TECHNOLOGIES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 169 PCR TECHNOLOGIES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 170 PCR TECHNOLOGIES MARKET: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 171 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 172 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 173 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 174 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 175 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 176 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 177 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 178 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 179 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 180 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 181 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 182 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 183 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 184 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 185 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 186 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 187 QIAGEN: COMPANY OVERVIEW
  • TABLE 188 QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 189 QIAGEN: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 190 QIAGEN: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 191 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 192 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 193 DANAHER CORPORATION: PRODUCT APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 194 DANAHER CORPORATION: DEALS, JANUARY 2021– AUGUST 2024
  • TABLE 195 ABBOTT: COMPANY OVERVIEW
  • TABLE 196 ABBOTT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 197 ABBOTT: PRODUCT APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 198 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 199 TAKARA BIO INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 200 TAKARA BIO INC.: DEALS, JANUARY 2021– AUGUST 2024
  • TABLE 201 ANALYTIK JENA GMBH+CO. KG: COMPANY OVERVIEW
  • TABLE 202 ANALYTIK JENA GMBH+CO. KG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 203 ANALYTIK JENA GMBH+CO. KG: PRODUCT LAUNCHES, JANUARY 2021– AUGUST 2024
  • TABLE 204 ANALYTIK JENA GMBH+CO. KG: DEALS, JANUARY 2021– AUGUST 2024
  • TABLE 205 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 206 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 207 BIONEER CORPORATION: COMPANY OVERVIEW
  • TABLE 208 BIONEER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 209 PERKINELMER: COMPANY OVERVIEW
  • TABLE 210 PERKINELMER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 211 PERKINELMER: OTHER DEVELOPMENTS, JANUARY 2021–AUGUST 2024
  • TABLE 212 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 213 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 214 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 215 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 216 STANDARD BIOTOOLS: COMPANY OVERVIEW
  • TABLE 217 STANDARD BIOTOOLS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 218 HOLOGIC, INC.: COMPANY OVERVIEW
  • TABLE 219 HOLOGIC, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 220 HOLOGIC, INC.: PRODUCT LAUNCHES, JANUARY 2021–AUGUST 2024
  • TABLE 221 LONZA: COMPANY OVERVIEW
  • TABLE 222 LONZA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 223 ILLUMINA, INC.: COMPANY OVERVIEW
  • TABLE 224 ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 225 SANSURE BIOTECH INC.: COMPANY OVERVIEW
  • TABLE 226 SANSURE BIOTECH INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 227 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 228 LIMINGBIO: COMPANY OVERVIEW
  • TABLE 229 EPPENDORF SE: COMPANY OVERVIEW
  • TABLE 230 TRANSGEN BIOTECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 231 DAAN GENE CO., LTD.: COMPANY OVERVIEW
  • TABLE 232 BIOBASE GROUP: COMPANY OVERVIEW
  • TABLE 233 NIPPON GENETICS EUROPE: COMPANY OVERVIEW
  • TABLE 234 BIOMÉRIEUX: COMPANY OVERVIEW
  • TABLE 235 DAIICHI SANKYO COMPANY, LIMITED: COMPANY OVERVIEW
  • TABLE 236 STILLA: COMPANY OVERVIEW
  • TABLE 237 GENSCRIPT: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 PCR TECHNOLOGIES MARKET: SEGMENTS CONSIDERED
  • FIGURE 2 PCR TECHNOLOGIES MARKET: YEARS CONSIDERED
  • FIGURE 3 PCR TECHNOLOGIES MARKET: RESEARCH DATA
  • FIGURE 4 PCR TECHNOLOGIES MARKET: RESEARCH DESIGN
  • FIGURE 5 PCR TECHNOLOGIES MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 6 PCR TECHNOLOGIES MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDES)
  • FIGURE 7 PCR TECHNOLOGIES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 8 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 9 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 10 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 11 PCR TECHNOLOGIES MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION
  • FIGURE 12 PCR TECHNOLOGIES MARKET: BOTTOM-UP APPROACH
  • FIGURE 13 PCR TECHNOLOGIES MARKET: TOP-DOWN APPROACH
  • FIGURE 14 DATA TRIANGULATION METHODOLOGY
  • FIGURE 15 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACROINDICATORS
  • FIGURE 16 PCR TECHNOLOGIES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 18 PCR TECHNOLOGIES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 19 PCR TECHNOLOGIES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 20 PCR TECHNOLOGIES MARKET: REGIONAL SNAPSHOT
  • FIGURE 21 INCREASING DEMAND FOR ADVANCED PCR TECHNOLOGIES TO DRIVE MARKET
  • FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING STUDY PERIOD
  • FIGURE 23 US AND DIAGNOSTIC LABORATORIES COMMANDED LARGEST MARKET SHARE IN 2023
  • FIGURE 24 CHINA TO REGISTER HIGHEST GROWTH RATE FROM 2024 TO 2030
  • FIGURE 25 PCR TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 PCR TECHNOLOGIES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 27 PCR TECHNOLOGIES MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 29 KEY BUYING CRITERIA FOR TOP FOUR END USERS
  • FIGURE 30 PATENT ANALYSIS FOR PCR TECHNOLOGIES (JANUARY 2014–AUGUST 2024)
  • FIGURE 31 AVERAGE SELLING PRICE TREND OF PCR TECHNOLOGY EQUIPMENT, BY REGION, 2021–2023 (USD)
  • FIGURE 32 AVERAGE SELLING PRICE OF PCR INSTRUMENTS, BY KEY PLAYER, 2023 (USD)
  • FIGURE 33 PCR TECHNOLOGIES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 34 PCR TECHNOLOGIES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 35 PCR TECHNOLOGIES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 36 INVESTMENT AND FUNDING SCENARIO, 2019–2023
  • FIGURE 37 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023
  • FIGURE 38 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)
  • FIGURE 39 PCR TECHNOLOGIES MARKET: IMPACT OF AI/GEN AI
  • FIGURE 40 NORTH AMERICA: PCR TECHNOLOGIES MARKET SNAPSHOT
  • FIGURE 41 ASIA PACIFIC: PCR TECHNOLOGIES MARKET SNAPSHOT
  • FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN PCR TECHNOLOGIES MARKET (2019–2023)
  • FIGURE 43 PCR INSTRUMENTS MARKET SHARE ANALYSIS (2023)
  • FIGURE 44 PCR REAGENTS AND CONSUMABLES MARKET SHARE ANALYSIS (2023)
  • FIGURE 45 PCR SOFTWARE AND SERVICES MARKET SHARE ANALYSIS (2023)
  • FIGURE 46 PCR TECHNOLOGIES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 47 PCR TECHNOLOGIES MARKET: COMPANY FOOTPRINT
  • FIGURE 48 PCR TECHNOLOGIES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 49 EV/EBITDA OF KEY VENDORS
  • FIGURE 50 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 51 PCR TECHNOLOGIES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 52 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 53 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • FIGURE 54 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 55 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 56 QIAGEN: COMPANY SNAPSHOT
  • FIGURE 57 DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 58 ABBOTT: COMPANY SNAPSHOT
  • FIGURE 59 TAKARA BIO INC.: COMPANY SNAPSHOT
  • FIGURE 60 MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 61 BIONEER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 62 PERKINELMER: COMPANY SNAPSHOT
  • FIGURE 63 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 64 STANDARD BIOTOOLS: COMPANY SNAPSHOT
  • FIGURE 65 HOLOGIC, INC.: COMPANY SNAPSHOT
  • FIGURE 66 LONZA: COMPANY SNAPSHOT
  • FIGURE 67 ILLUMINA, INC.: COMPANY SNAPSHOT
  • FIGURE 68 SANSURE BIOTECH INC.: COMPANY SNAPSHOT

Major activities have been focused to estimate the market size of the PCR technologies sector at present. Extensive secondary research has been conducted to collate information regarding the PCR industry. The next step involved primary research with industry experts along the value chain to validate these findings, assumptions, and market sizing. Many different methodologies were used for estimating the overall market size, involving the top-down and bottom-up approaches. To do so, we employed market segmentation and data triangulation techniques to get an accurate market size across different market segments and subsegments of the PCR technologies market.

Secondary Research

Secondary research sources of this study include directories and databases, such as D&B Hoovers and Factiva; white papers; Bloomberg Businessweek; annual reports; SEC filings; business filings; and investor presentations. The above sources have given information on leading companies and market segmentation that reflects the industry trend and technological perspectives of the PCR technologies market .

Primary Research

Major research activities entailed interviewing the supply side and the demand side, using both a quantitative and qualitative approach to data collection. Supply side information was obtained from key informants like CEOs, area sales managers, territory sales managers, regional sales managers, and other high-level officials from leading companies, while on the demand side, it mainly comprised physicians, researchers, department heads, and staff from diagnostic centers, hospitals, and research institutions. This study was conducted for the purpose of ensuring that assumptions were validated through interaction with relevant stakeholders.

A breakdown of the primary respondents is provided below:

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

This research involves revenue sharing review of the leading players in the PCR technologies market. Primary and secondary research methods were adopted to determine the key players in the industry and to gain some level of understanding of their financial performance and market share. The primary research was more detailed interviews taken from the CEOs, directors, and senior marketing executives, whereas the secondary research primarily relied upon the annual and financial reports issued by the major players in the industry. A segment-based strategy was followed to determine the market value across the globe, and the revenue details of the leading solution providers were further used to differentiate between sources and services.

Procedures Covered:

Identify the companies around the world who are leading PCR technologies industry and note down their respective annual revenues or specific product category/business division.

The revenue mapping of the key competitors, based on 2024, is in fact a major share of the market for this analysis, thus extrapolated to total global value for the PCR technologies market.

Data Triangulation

The PCR technologies market is segmented into various segments and subsegments based on the methodology adopted in this report. Data triangulation and the segmentation process are next undertaken to ensure the accuracy of data for all segments. Drivers and trends have been identified from both the supply and demand sides. The results obtained from both the top-down and bottom-up approaches have been utilized for deriving the results of the PCR technologies market analysis.

Market Definition

The PCR (Polymerase Chain Reaction) technologies market involves the biotechnology and health industries specializing in product and service offerings related to PCR techniques. PCR is a molecular biology technique allowing targeted amplification of DNA sequences so that genetic material may be examined. This market encompasses several sub-components, including the equipment, like thermal cyclers and real-time PCR machines, and consumables, including reagents, enzymes, primers, and kits, for the PCR process. Applications of PCR include research, clinical diagnostics, genetic testing, forensic analysis, and environmental studies. Among the driving factors behind this market are technological developments, including digital PCR and multiplex PCR that advance sensitivity and specificity in instruments. Future growth in the market is expected due to increased research activities, increased incidence of genetic disorders, and continuous innovative developments in biotechnology.

Stakeholders

  • Manufacturers and distributors of PCR Technologies   devices
  • Healthcare institutions (hospitals and clinics)
  • Diagnostic centers
  • Healthcare institutions (hospital Labs)
  • Research institutions.
  • Research and consulting firms.
  • Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
  • Academic medical centers and universities
  • Market research and consulting firms
  • Clinical research organizations
  • Pharma-Biotech Companies
  • Group Purchasing Organizations (GPOs)
  • Medical Research Laboratories
  • Academic Medical Centers and Universities
  • Accountable Care Organizations (ACOs)

Report Objectives

  • To define, describe, and forecast the global PCR Technologies market based on product, application, technique, end user, and region.
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile the key market players and comprehensively analyze their market shares and core competencies2
  • To forecast the revenue of the market segments in five main regions: North America (the US and Canada), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), the Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Africa)
  • To track and analyze competitive developments such as product launches and approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the PCR Technologies   market.

Previous Versions of this Report

PCR Technologies Market by Technique (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene Expression, Diagnostics), End User (Academia, Pharma-Biotech, Applied) - Global Forecast to 2027

Report Code AST 7880
Published in Oct, 2024, By MarketsandMarkets™

PCR Technologies Market by Technique (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene Expression, Diagnostics), End User (Academia, Pharma-Biotech, Applied) - Global Forecast to 2027

Report Code AST 7880
Published in Nov, 2022, By MarketsandMarkets™

PCR Technologies Market by Technique (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene Expression, Diagnostics), End User (Academia, Pharma-Biotech, Applied) - Global Forecast to 2027

Report Code AST 7880
Published in Apr, 2021, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in PCR Technologies Market

DMCA.com Protection Status